Spacer sequences of 42 and 127 bp, respectively, between the ISEcp1 insertion sequence and bla CTX-M have been observed in Klebsiella pneumoniae. However, it is not known whether different spacers upstream of bla CTX-M and a promoter within the 127 bp spacer influence cephalosporin resistance. Three recombinant plasmids with different spacers and with or without ISEcp1 were constructed to compare bla CTX-M-3 expression and susceptibility to cephalosporins. Our experiment revealed enhanced bla CTX-M-3 expression and a relatively high level resistance to cefotaxime and cefepime in recombinant plasmid IS42CTX-M-3, which contained ISEcp1 and the 42 bp spacer. A minor difference in bla CTX-M-3 expression was observed in recombinants IS127CTX-M-3 and 127CTX-M-3, which contained a 127 bp spacer with or without ISEcp1, respectively. In conclusion, the promoter within ISEcp1 and a shorter spacer (42 bp but not 127 bp) between ISEcp1 and bla CTX-M are necessary for high-level bla CTX-M-3 expression.
INTRODUCTION
The CTX-M-type b-lactamase has become the most prevalent extended-spectrum b-lactamase (ESBL) (Bonnet, 2004; Cantó n & Coque, 2006) . Correlation between bla CTX-M genes and the ISEcp1 insertion sequence has verified the influence of ISEcp1 not only on expression, but also in mobilization and acquisition of bla CTX-M (Karim et al., 2001; Lartigue et al., 2004; Messai et al., 2008; Poirel et al., 2003 Poirel et al., , 2005 Rodríguez et al., 2004; Tamang et al., 2011; Woodford et al., 2004) . ISEcp1B or ISEcp1 harbours promoter sequences for the high-level expression of bla CTX-M-14 , bla CTX-M-15 , bla CTX-M-17 and bla (Bonnet, 2004; Cao et al., 2002; Poirel et al., 2003; Tamang et al., 2011) . ISEcp1 also plays an important role upstream of various resistance genes including ampC, rmtC, qnrB-like and bla CMY-2 -like genes (Cattoir et al., 2008; Haldorsen et al., 2008; Verdet et al., 2009; Wachino et al., 2006) . Four differently sized spacer sequences (bla , 42 bp; bla CTX-M-10 , bla CTX-M-15 , 48 bp; bla CTX-M-1 , 79 bp; and bla CTX-M-3 , 127 bp) separating the inverted repeat right (IRR) of ISEcp1 from the ATG site of the bla CTX-M genes have been reported (Eckert et al., 2006; Lartigue et al., 2004; Messai et al., 2008; Saladin et al., 2002) . Among the six subgroups of CTX-M enzymes (Rossolini et al., 2008) , the predominant CTX-M-type ESBLs in Taiwan are CTX-M-3 and CTX-M-14, which belong to the bla CTX-M-1 and bla CTX-M-9 subgroup, respectively (Yu et al., 2006) . Our previous study on 235 ESBL-producing Klebsiella pneumoniae isolates in Taiwan revealed that all CTX-M-type ESBLs, including the bla CTX-M-1 and bla CTX-M-9 subgroups, possess ISEcp1 upstream of bla CTX-M (Ma et al., 2009) . Either a 42 bp or 127 bp spacer sequence is present between ISEcp1 and the ATG start codon of bla CTX-M in these clinical isolates. For all bla CTX-M-3 isolates, the spacer sequence is 127 bp upstream of bla CTX-M-3 , but most bla CTX-M-14 -harbouring isolates have a spacer of 42 bp. One putative promoter sequence has been predicted in the 127 bp spacer sequence (GenBank accession no. AF550415) (Eckert et al., 2006; Gołebiewski et al., 2007) . No promoter has been observed within the 42 bp spacer sequence. However, no experiment has proven the function of this predicted promoter in the 127 bp spacer sequence. Furthermore, the influence of spacer sequence size on the strength of b-lactamase expression has not been addressed.
In this study, we aimed to determine whether the existence of an additional promoter within the 127 bp spacer sequence upstream of bla CTX-M-3 could influence the expression of bla CTX-M-3 . We compared the expression of bla CTX-M-3 with three combinations of spacer sequences and ISEcp1 upstream of bla CTX-M-3 .
isolate producing CTX-M-3 and one producing CTX-M-14 with a 127 and 42 bp spacer sequence, respectively, between ISEcp1 and bla CTX-M were selected as template DNA source for plasmid reconstructions. A rifampicin-resistant strain of Escherichia coli (strain JP-995) was used as the recipient (Siu et al., 1997) . Recipients and donors were separately inoculated into brain heart infusion broth (Oxoid) and incubated at 37 uC for 4 h. They were then mixed at a ratio of 1 : 10 (v/v) for overnight incubation at 37 uC. A 0.1 ml volume of the overnight broth mixture was spread onto MacConkey agar containing rifampicin (100 mg ml
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) and cefotaxime (2 mg ml
). Transconjugants were then selected. T-42-CTX-M-14 was E. coli JP-995 with ISEcp1-42 bp spacer-CTX-M-14. T-127-CTX-M-3 was E. coli JP-995 with ISEcp1-127 bp spacer-CTX-M-3. Antibiotic susceptibility was determined by the broth microdilution method (CLSI, 2006) , according to the Clinical and Laboratory Standards Institute guidelines (CLSI, 2007) . We rechecked the MIC with Etest (bioMérieux) when the MIC was above 256 mg ml 21 by the broth microdilution method.
Construction of three plasmids with different spacer sequences with or without ISEcp1 upstream of bla CTX-M-3 .
The sequence between bla CTX-M-14 and ISEcp1 was 42 bp and that between bla CTX-M-3 and ISEcp1 was 127 bp in our screened isolates.
To compare the influence of the promoter, bla CTX-M-3 was selected as a reporter gene. Three recombinant plasmids containing the entire bla CTX-M-3 gene, with or without the ISEcp1-borne promoter sequences, were constructed. Transconjugants with ISEcp1 and 42 or 127 bp spacer sequences were used as a template to construct the three recombinant plasmids (Fig. 1) by insertion of blunt-end PCR products into the EcoRV site of plasmid pACYC184. Recombinant plasmids pAC127 and pACISEcp127 were constructed using PCRamplified DNA fragments with the primers listed in Table 1 . Recombinant plasmid pAC127 was constructed using primers 127-F and 127-R and had the 127 bp sequence separating the IRR of ISEcp1 from the ATG start codon of bla CTX-M-3 . Recombinant plasmid pACISEcp127 was constructed with primers IS127-F and IS127-R. The plasmid included ISEcp1 and the 127 bp spacer sequence separating it from bla CTX-M-3 . Recombinant plasmid pACISEcp42 was constructed by overlapping PCR. Fragment 1 included ISEcp1 and the 42 bp sequence separating it from bla CTX-M-3 . The forward primer was the same as IS127-F. The reverse primer, 42-R, had an overlapping sequence with the start of bla CTX-M-3 . Fragment 2 included the whole sequence of bla CTX-M-3 . The primer set for fragment 2 was CTX-M-3-F and CTX-M-3-R. Three recombinant plasmids were transformed into E. coli reference strain DH5a and the transformant strains were designated 127CTX-M-3, IS127CTX-M-3 and IS42CTX-M-3, respectively ( Fig. 1 ).
RNA extraction and primer extension analysis. Overnight cultures were diluted 1 : 100 in LB medium and grown to midexponential phase (OD 600 50.8) at 37 uC with shaking. Aliquots (3 ml) were pelleted by centrifugation at 12 000 g for 15 min and lysed with 1 ml TRIzol reagent (Invitrogen). Homogenized samples were incubated for 5 min at room temperature with vigorous shaking in 0.1 ml 1-bromo-3-chloropropane, incubated at room temperature for 15 min, and centrifuged for 15 min at 12 000 g. The RNA that distributed into the aqueous phase was precipitated with 0.5 ml ice-cold isopropyl alcohol. The RNA pellet was washed with 1 ml 70 % ethanol, air-dried for 10 min, and dissolved in 30 ml diethylpyrocarbonate water at 55 uC. The total RNA concentration was measured using a BioPhotometer apparatus (Eppendorf). A 1 mg portion of total RNA was mixed with 1 U Baseline-ZERO DNase (Epicenter) in 2 ml 106 Baseline-ZERO DNase reaction buffer for 30 min at 37 uC. The DNase was inactivated with 2 ml 106 Baseline-ZERO DNase stop followed by 10 min at 65 uC.
Primer extension was performed with the SuperScript First-Strand synthesis system for reverse transcriptase (RT)-PCR (Invitrogen). cDNA was generated from the CTX-M-3 REV primer (59-CCATCAGCGTGAACTGGCGCA-39), which had been previously 59-end-labelled with a fluorescent dye (6-FAM). Sample analyses were performed by the nucleic acid analysis service at Mission Biotech, Taiwan.
RT-PCR. The transcriptional expression of bla CTX-M of pACISEcp42, pAC127 and pACISEcp127 was analysed by RT-PCR. cDNA was synthesized using the SuperScript First-Strand synthesis system (Invitrogen). Differences in gene expression were estimated by PCR using the target-specific primers CTX-MA and CTX-MB (Bonnet et al., 2001) . Amplifications were performed with an initial step of 5 min at 95 uC followed by 25 cycles of 30 s at 94 uC, 30 s at 56 uC and 30 s at 72 uC. Constitutive expression of the 16S rRNA gene assessed in the same cDNA preparation was used as a control, using primers 16S rRNA-F and 16S rRNA-R (Table 1) (Ping et al., 2007) . The level of gene expression was estimated by comparison of Fig. 1 . Structure of the three recombinant plasmids used in this study. Recombinant plasmid pAC127 possesses only its own promoter. Recombinant plasmid pACISEcp127 possesses both an ISEcp1-provided promoter and its own promoter. Recombinant plasmid pACISEcp42 has only the ISEcp1-provided promoter.
the band intensities on a 1 % agarose gel containing ethidium bromide.
b-Lactamase activity. Hydrolysis of 25 mM cefotaxime (SigmaAldrich) was monitored by UV spectrophotometry at 254 nm and 37 uC in 10 mM phosphate buffer (pH 7.0). Activity was standardized relative to protein concentration and was determined by the Bio-Rad protein assay, which was based on the Bradford method (Bradford, 1976) . BSA was used as the standard. b-Lactamase activity was assayed by growing bacterial cultures overnight in nutrient broth, diluting 10-fold into fresh broth, and incubating for 4 h. The cells were harvested into 2 ml vols 10 mM phosphate buffer (pH 7.0), disrupted by three cycles of freezing and thawing, and sonicated. Debris was removed by centrifugation at 6000 g for 30 min, and the supernatants were retained at 220 uC and assayed against cefotaxime.
RESULTS
The antimicrobial susceptibility testing results of two transconjugants and three plasmid recombinants are presented in Table 2 . The three recombinants, 127CTX-M-3, IS127CTX-M-3 and IS42CTX-M-3, were resistant to cefotaxime based on their MICs of ¢64 mg ml
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. IS42CTX-M-3 displayed a trend to higher MICs of aztreonam, ceftazidime and cefepime than did IS127CTX-M-3 and 127CTX-M-3. The MIC of cefotaxime for IS42CTX-M-3 was ¢512 mg ml 21 by Etest. IS42CTX-M-3 had more than fourfold increased MICs of cefotaxime, cefepime and aztreonam than did IS127CTX-M-3 and 127CTX-M-3. The two transconjugants, T-42-CTX-M-14 with the ISEcp1-42 bp spacer- Effect of spacer sequences on bla CTX-M expression bla CTX-M-14 -containing plasmid and T-127-CTX-M-3 with the ISEcp1-127 bp spacer-bla CTX-M-3 -containing plasmid, also had high cefotaxime MICs. The MIC of cefepime for T-42-CTX-M-14 was fourfold higher than that for T-127-CTX-M-3. The MIC of cefepime for recombinant IS42CTX-M-3 was ¢256 mg ml
, which is higher than the MIC of cefepime (16 mg ml
) for transconjugant T-127-CTX-M-3.
Primer extension experiments indicated that the transcription start site was located 16 bp upstream of the ATG start codon of bla CTX-M-3 for the 127CTX-M-3 recombinant. The 235 (TTGACT) and 210 (TTTCGT) promoter sequences in the 127 bp spacer sequence were separated by 16 bp. The 235 region is closely related to the consensus motif TTGACA (Lewin, 2006) (Fig. 2 ).
Significant differences in RNA transcriptions were observed that indicated enhanced expression of bla CTX-M-3 in IS42CTX-M-3 in comparison to IS127CTX-M-3 and 127CTX-M-3 (Fig. 3) . Regarding b-lactamase activity, cefotaximase specific activity was up to 16-fold higher in strain IS42CTX-M-3 [mean±SD, 2961±174 nmol cefotaxime hydrolysed min 21 (mg protein)
] than in strain IS127CTX-M-3 (184±14 nmol min 21 mg
), and 9.3-fold higher in strain IS42CTX-M-3 than in strain 127CTX-M-3 (318±16 nmol min 21 mg
).
RNA secondary structure prediction with the Vienna RNA Secondary Structure Prediction website (http://rna.tbi. univie.ac.at/cgi-bin/RNAfold.cgi) revealed the free energy of formation in the double promoter region can readily form RNA secondary structure in the double promoter region for IS127CTX-M-3 (Fig. 4) .
DISCUSSION
In the GenBank database, the upstream region (127 bp ). This may be related to fact that the bla CTX-M-1 and bla CTX-M-9 subgroups originated from different Kluyvera species (Bonnet et al., 2001; Rodríguez et al., 2004; Rossolini et al., 2008) . ISEcp1B, which differs from ISEcp1 by three nucleotide substitutions and an amino acid change in transposase, has a promoter function for the high-level expression of b-lactamase genes (Poirel et al., 2003) . The promoter sequences 235 (TTGAAA) and 210 (TACAAT) were identified in ISEcp1B near its IRR in bla CTX-M-17 and bla CTX-M-19 Poirel et al., 2003) . The 127 bp spacer sequence upstream of bla CTX-M-3 in our study was the same as the published bla CTX-M-1 subgroup upstream sequences of GenBank accession numbers AF550415 (CTX-M-3) and DQ061159 (CTX-M-42) and Kluyvera ascorbata (Eckert et al., 2006; Rodríguez et al., 2004) . In contrast to the plasmid-located bla CTX-M-3 where ISEcp1 and a 127 bp spacer were present upstream, the chromosome-located bla CTX-M-3 was preceded only by a 127 bp spacer without ISEcp1 in K. ascorbata (Rodríguez et al., 2004 (Lewin, 2006) . Such a 210 sequence has also been described in Geobacter sulfureducens (Nú ñez RT-PCR and b-lactamase activity assays showed that the transcript levels and hydrolytic activity for cefotaxime of the three constructed plasmids were as follows: IS42CTX-M-3.127CTX-M-3.IS127CTX-M-3. The difference in the expression of IS42CTX-M-3 and 127CTX-M-3 revealed that the ISEcp1-provided promoter is stronger than the promoter in the 127 bp spacer sequence. This is similar to the case of ISAba1 in Acinetobacter baumannii, where only those isolates with ISAba1 upstream and adjacent to the bla OXA-51-like gene display imipenem and/or meropenem resistance (Turton et al., 2006) . Our work on bla CTX-M-3 confirmed the previous findings that the adjacent ISEcp1 acts as a strong promoter for bla CTX-M .
Comparison of the cefotaximase expression of IS42CTX-M-3 and IS127CTX-M-3 strains revealed that, although IS127CTX-M-3 possesses two upstream promoters, it has lower cefotaximase expression and hydrolytic activity than IS42CTX-M-3. The difference in distance of ISEcp1 to the start of bla CTX-M-3 may contribute to the difference in promoter strength between IS42CTX-M-3 and IS127CTX-M-3. A similar situation was that the deletion of a sevennucleotide portion in the spacer sequence between the qnrA gene and its promoter made the promoter closer to the qnrA gene and increased the MIC of ciprofloxacin (Xu et al., 2007) . In our study, when ISEcp1 was closer to bla CTX-M-3 (42 bp), enhanced b-lactamase activity was expressed.
IS127CTX-M-3 and 127CTX-M-3 displayed no significant difference in MIC level. IS127CTX-M-3 has two promoters, but displayed lower cefotaximase expression and activity than 127CTX-M-3. Although formation of RNA secondary structure in the double promoter region in IS127CTX-M-3 is predicted, it remains to be assessed whether RNA secondary structure formation, which may weaken the promoter action, does change its promoter activity.
The MIC values for the transconjugants and the plasmid recombinants were not the same. For example, the MIC of cefepime was low (4 mg ml
21
) for T-42-CTX-M-14 compared to that for IS42-CTX-M-3 (¢256 mg ml 21 ). Although both had ISEcp1 and the 42 bp spacer sequence, this could be due to the difference in the recipient strains of the transconjugant and the plasmid recombinant. Also, CTX-M-3 and CTX-M-14 are of different subgroups of CTX-M and confer different cefepime MIC profiles, as demonstrated in Table 2 , which is a limitation of the study. Though we observed that the promoter region functions better in the transconjugant than in the recombinant, the actual reasons were not identified.
In conclusion, even though a promoter for CTX-M is present in the 127 bp sequence upstream of the bla CTX-M gene in the CTX-M-1 subgroup, our results demonstrate that the promoter within ISEcp1 is more important. Both the promoter within ISEcp1 and its shorter distance (42 bp) to bla CTX-M are necessary to result in high-level bla CTX-M expression.
